Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects

American Journal of Cardiology

Volumn 84, Issue 3, 1999, Pages 316-320

  Andrews, Neil P ^a   Goldstein, David S ^a   Quyyumi, Arshed A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; YOHIMBINE;

ADRENERGIC RECEPTOR BLOCKING; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY POSTURE; CARDIOVASCULAR RISK; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BLOOD CELL COUNT; BLOOD PRESSURE; CATECHOLAMINES; CIRCADIAN RHYTHM; CONFOUNDING FACTORS (EPIDEMIOLOGY); EXERCISE; HEART RATE; HUMANS; MALE; PLATELET AGGREGATION; POSTURE; RECEPTORS, ADRENERGIC, ALPHA-2; REFERENCE VALUES; YOHIMBINE;

EID: 0033180059     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00283-0     Document Type: Article

References (28)

1. Muller J.E., Stone P.H., Turi Z.G., Rutherford J.P., Czeisler C.A., Parker C., Poole W.K., Passamani E., Roberts R., Robertson T., Sobel B.E., Willerson J.T., Braunwald E. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 313:1985;1315-1322.
2. Willich S.N., Levy D., Rocco M.B., Tofler G.H., Stone P.H., Muller J.E. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study Population. Am J Cardiol. 60:1987;801-806.
3. Willich S.N., Goldberg R.J., Maclur M., Perriello L., Muller J.E. Increased onset of sudden cardiac death in the first three hours of awakening. Am J Cardiol. 70:1992;65-68.
4. Tofler G.H., Brezinski D.A., Schafer A., Czeisler C.A., Rutherford J.D., Willich S.N., Gleason R.E., Williams G.H., Muller J.E. Morning increase in platelet responsiveness to ADP and epinephrine association with the time of increased risk of myocardial infarction and sudden cardiac death . N Engl J Med. 316:1987;1514-1518.
5. Brezinski D.A., Tofler G.H., Muller J.E., Pohjola-Sintonen S., Willich S.N., Schafer A.L., Czeisler C.A., Williams G.H. Morning increase in platelet aggregability. Association with assumption of the upright posture. Circulation. 78:1988;35-40.
6. Willich S.N., Pohjola-Sintonen S., Bhatia S.J., Shook T.L., Tofler G.H., Muller J.E., Curtis D.G., Williams G.H., Stone P.H. Suppression of silent ischemia by metoprolol without alteration of the morning increase of platelet aggregability in patients with stable coronary artery disease. Circulation. 79:1989;557-565.
7. Mittleman M.A., Maclure M., Tofler G.H., Sherwood J.B., Goldberg R.J., Muller J.E. Triggering of acute myocardial infarction by heavy physical exertion- protection against triggering by regular exertion. N Engl J Med. 329:1993;1677-1683.
8. Willich S.N., Lewis M., Löwel H., Arntz H.-R., Schubert F., Schröder R. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med. 329:1993;1684-1690.
9. Wang J., Jen C.J., Kung H., Lin L.-J., Hsiue T.-R., Chen H. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation. 90:1994;2877-2885.
10. Kestin A.S., Ellis P.A., Barnard M.R., Errichett A., Rosner B.A., Michelson A.D. Effect of strenuous exercise on platelet activation state and reactivity. Circulation. 88:1993;1502-1511.
11. O'Brien J.R. Some effects of adrenaline and anti-adrenaline compounds on platelets in vitro and in vivo. Nature. 200:1963;763-764.
12. Lanza F., Beretz A., Stierlé A., Hanau D., Kubina M., Cazenave J.-P. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol. 255:1988;H1276-H1288.
13. Hjemdahl P., Chronos N.A.F., Wison D., Bouloux P., Goodhall A.H. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler Thromb. 14:1994;77-84.
14. Larsson P.T., Wallén N.H., Egberg N., Hjemdahl P. Alpha-adrenoreceptor blockade by phentolamine inhibits adrenaline-induced activation in vivo without affecting resting measurements. Clin Sci. 82:1992;369-376.
15. Larsson P.T., Wallén N.H., Martinsson A., Egberg N., Hjemdahl P. Significance of platelet α adrenoceptors for platelet responses in vivo and in vitro. Thromb Haemost. 68:1992;687-693.
16. Ardlie N.G., McGuiness J.A., Garrett J.J. Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis. 58:1985;251-259.
17. Ardlie N.G., Cameron H.A., Garrett J.J. Platelets activation by circulating levels of hormones a possible link in coronary heart disease . Thromb Res. 36:1984;315-322.
18. Diodati J.D., Cannon R.O., Epstein S.E., Quyyumi A.A. Platelet activation across the coronary bed in patients with stable coronary artery disease. Circulation. 86:1992;1186-1193.
19. Biaggoni I., Robertson R.M., Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol. 34:1994;418-423.
20. Eisenhofer G., Goldstein D.S., Stull R., Keiser H.R., Sunderland T., Murphy D.L., Kopin I.J. Simultaneous liquid chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma and their response to inhibition of monoamineoxidase. Clin Chem. 32:1986;2030-2033.
21. Guthrie S.K., Hariharan M., Grunhaus L.J. Yohimbine bioavailability in humans. Eur J Clin Pharmacol. 3:1990;409-411.
22. Robertson D., Johnson G.A., Robertson R.M. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation. 59:1979;637-643.
23. Larsson P.T., Wallén N.H., Hjemdahl P. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation. 89:1994;1951-1957.
24. Siess W., Lorenz R., Roth P., Weber P.C. Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion. Circulation. 66:1982;44-48.
25. Reiss H., Braun G., Brehm G., Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol. 85:1986;50-56.
26. Cardinal D.C., Flower R.J. The electronic aggregometer a novel device for assessing platelet behavior in whole blood . J Pharmacol Meth. 3:1980;135-158.
27. Le Verge R., Le Corre P., Chevane F. Determination of yohimbine and its two hydroxylated metabolites in humans by high performance liquid chromatography and mass spectral analysis. J Chromatogr. 574:1992;283-292.
28. 2-adrenoceptor antagonist potencies of two hydroxylated metabolities of yohimbine. Br J Pharmacol. 108:1993;927-932.